BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24905250)

  • 1. Will I have a heart attack or stroke if I take testosterone therapy?
    Morgentaler A
    J Sex Med; 2014 Jun; 11(6):1601-2. PubMed ID: 24905250
    [No Abstract]   [Full Text] [Related]  

  • 2. In brief: testosterone and cardiovascular risk.
    Med Lett Drugs Ther; 2014 Mar; 56(1437):17. PubMed ID: 24589496
    [No Abstract]   [Full Text] [Related]  

  • 3. Testosterone: myocardial infarction and stroke.
    Prescrire Int; 2014 Oct; 23(153):240-1. PubMed ID: 25964971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Testosterone Products: Drug Safety Communication - FDA Cautions about Using Testosterone Products for Low Testosterone due to Aging; Requires Labeling Change to Inform of Possible Increased Risk of Heart Attack and Stroke.
    Seftel AD
    J Urol; 2015 Sep; 194(3):759-60. PubMed ID: 26292880
    [No Abstract]   [Full Text] [Related]  

  • 5. [Heart risk due to testosterone?].
    Grätzel P
    MMW Fortschr Med; 2015 Apr; 157(6):27. PubMed ID: 26015192
    [No Abstract]   [Full Text] [Related]  

  • 6. Malignant medication? Testosterone and cancer.
    Pastuszak AW
    BJU Int; 2015 Feb; 115(2):179-80. PubMed ID: 25604717
    [No Abstract]   [Full Text] [Related]  

  • 7. Bodybuilding, exogenous testosterone use and myocardial infarction.
    Major RW; Pierides M; Squire IB; Roberts E
    QJM; 2015 Aug; 108(8):651-2. PubMed ID: 25140029
    [No Abstract]   [Full Text] [Related]  

  • 8. Testosterone therapy and prostate cancer--safety concerns are well founded.
    Klotz L
    Nat Rev Urol; 2015 Jan; 12(1):48-54. PubMed ID: 25563848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone and cardiovascular risk: world's experts take unprecedented action to correct misinformation.
    Morgentaler A; Lunenfeld B
    Aging Male; 2014 Jun; 17(2):63-5. PubMed ID: 24797617
    [No Abstract]   [Full Text] [Related]  

  • 10. RE: Testosterone treatment is a potent tumor promoter for the rat prostate.
    Traish AM; Morgentaler A; Khera M
    Endocrinology; 2015 Jan; 156(1):L1-2. PubMed ID: 25526553
    [No Abstract]   [Full Text] [Related]  

  • 11. Words of wisdom. Re: Testosterone treatment is a potent tumor promoter for the rat prostate.
    Scovell JM; Butler P; Ramasamy R; Lamb DJ
    Eur Urol; 2015 Apr; 67(4):814-5. PubMed ID: 25765210
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostate cancer after exogenous testosterone replacement therapy in a patient with pituitary insufficiency.
    Halland A; Jønler M; Pedersen KV
    Scand J Urol Nephrol; 2005; 39(1):87-8. PubMed ID: 15764279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Author's response to RE: Testosterone treatment is a potent tumor promoter for the rat prostate.
    Bosland MC
    Endocrinology; 2015 Jan; 156(1):L3-4. PubMed ID: 25526554
    [No Abstract]   [Full Text] [Related]  

  • 14. Exogenous Testosterone Abuse and Myocardial Infarction in a Young Bodybuilder.
    Tan BE; Chowdhury M; Hall C; Baibhav B
    Am J Med; 2020 Nov; 133(11):e665-e666. PubMed ID: 32416180
    [No Abstract]   [Full Text] [Related]  

  • 15. Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study.
    Wallis CJ; Lo K; Lee Y; Krakowsky Y; Garbens A; Satkunasivam R; Herschorn S; Kodama RT; Cheung P; Narod SA; Nam RK
    Lancet Diabetes Endocrinol; 2016 Jun; 4(6):498-506. PubMed ID: 27165609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone and cardiovascular disease.
    Schooling CM; Lin X
    Lancet Diabetes Endocrinol; 2014 Aug; 2(8):612. PubMed ID: 25182458
    [No Abstract]   [Full Text] [Related]  

  • 17. Testosterone and cardiovascular disease.
    Jones TH
    Lancet Diabetes Endocrinol; 2014 Aug; 2(8):612-3. PubMed ID: 25182457
    [No Abstract]   [Full Text] [Related]  

  • 18. Testosterone and cardiovascular disease--author's reply.
    Page ST
    Lancet Diabetes Endocrinol; 2014 Aug; 2(8):613. PubMed ID: 25182459
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostate cancer risk in testosterone-treated men.
    Raynaud JP
    J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):261-6. PubMed ID: 17113983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editor's Comment--How Dangerous is Testosterone Supplementation?
    Jenkins LC; Mulhall JP
    Int Braz J Urol; 2015; 41(2):195-8. PubMed ID: 26005958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.